Overview

Open Trial Determining Antidepressant Effects of Omega-3 Supplementation During Pregnancy

Status:
Terminated
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if omega-3 polyunsaturated fatty acids as a monotherapy have antidepressant effects during pregnancy. It will also provide pilot data pertaining to relationships between apparent response to omega-3 monotherapy and both plasma cytokine and erythrocyte essential fatty acid concentrations.
Phase:
Early Phase 1
Details
Lead Sponsor:
William Coryell
Treatments:
Antidepressive Agents